Published in Diabet Med on January 14, 2008
An overview of preoperative glucose evaluation, management, and perioperative impact. J Diabetes Sci Technol (2009) 0.87
Perioperative management of patients with diabetes undergoing ambulatory elective surgery. J Diabetes Sci Technol (2013) 0.82
Effect of perioperative intensive insulin therapy for liver dysfunction after hepatic resection. World J Surg (2011) 0.81
Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery. Cardiovasc Diabetol (2011) 0.79
Hospital diabetes: why quality of care matters to both patients and hospitals. J Diabetes Sci Technol (2011) 0.78
Relationship between the timing of preoperative medical visits and day-of-surgery glucose in poorly controlled diabetes. Future Sci OA (2016) 0.75
Use of a glucose management service improves glycemic control following vascular surgery: an interrupted time-series study. Jt Comm J Qual Patient Saf (2015) 0.75
Update on a Quality Initiative to Standardize Perioperative Care for Continuous Subcutaneous Insulin Infusion Therapy. J Diabetes Sci Technol (2015) 0.75
Glucose metabolism in cardiovascular surgery. HSR Proc Intensive Care Cardiovasc Anesth (2010) 0.75
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med (1999) 5.21
Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation (2001) 3.03
Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J (2004) 2.73
Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome, a report from GUSTO IV-ACS. Eur Heart J (2004) 2.67
Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation (1993) 2.32
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
Concern Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J (2001) 2.26
Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker. Eur Heart J (2002) 2.06
Challenging the evidence for pre-emptive coil embolisation of the internal iliac artery during endovascular aneurysm repair. Eur J Vasc Endovasc Surg (2013) 2.00
Aortic surgery complications evaluated by an implanted continuous electrocardiography device: a case report. Eur J Vasc Endovasc Surg (2010) 1.96
Left ventricular hypertrophy screening using a hand-held ultrasound device. Eur Heart J (2002) 1.95
Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J (2002) 1.87
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization. Eur Heart J (2005) 1.83
Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation (1995) 1.81
Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol (1997) 1.74
Management of patients with heart failure in clinical practice: differences between men and women. Heart (2007) 1.73
Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms. J Nucl Med (2001) 1.70
Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol (1996) 1.70
Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT. Eur Heart J (2000) 1.62
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol (1999) 1.60
Non-compaction cardiomyopathy-echocardiographic diagnosis. Eur J Echocardiogr (2002) 1.59
Safety and prognostic value of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic electrocardiogram. Eur Heart J (2000) 1.55
Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J (2000) 1.55
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain. Heart (2008) 1.55
COPD and cancer mortality: the influence of statins. Thorax (2009) 1.53
No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum (2009) 1.53
Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification. Eur J Vasc Endovasc Surg (2009) 1.51
Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation (1997) 1.51
Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart (2006) 1.50
Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol (2001) 1.48
Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting. J Nucl Cardiol (1999) 1.44
Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation (2001) 1.44
Perioperative blood glucose monitoring and control in major vascular surgery patients. Eur J Vasc Endovasc Surg (2009) 1.43
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab (2001) 1.43
No differences in perioperative outcome between symptomatic and asymptomatic AAAs after EVAR: an analysis from the ENGAGE Registry. Eur J Vasc Endovasc Surg (2012) 1.42
Systematic review of utilities in abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2008) 1.42
Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris. Am J Cardiol (2001) 1.42
Cardiac CT and CT coronary angiography: technology and application. Heart (2008) 1.42
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J (2001) 1.42
EVAR suitability is not a predictor for early and midterm mortality after open ruptured AAA repair. Eur J Vasc Endovasc Surg (2011) 1.41
Flow velocity and predictors of a suboptimal coronary flow velocity reserve after coronary balloon angioplasty. Eur Heart J (2002) 1.41
Reprinted article "A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery". Eur J Vasc Endovasc Surg (2011) 1.40
[Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia]. Ned Tijdschr Geneeskd (2006) 1.40
[Screening of asymptomatic individuals for coronary disease using CT-calcium measurement in the coronary arteries]. Ned Tijdschr Geneeskd (2006) 1.40
Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium. J Nucl Cardiol (1999) 1.40
Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol (1996) 1.40
Early results from the ENGAGE registry: real-world performance of the Endurant Stent Graft for endovascular AAA repair in 1262 patients. Eur J Vasc Endovasc Surg (2012) 1.39
Smoking cessation has no influence on quality of life in patients with peripheral arterial disease 5 years post-vascular surgery. Eur J Vasc Endovasc Surg (2010) 1.39
[Prophylactic perioperative beta-blockade reduces cardiac morbidity and mortality following non-cardiac surgery in patients at risk]. Ned Tijdschr Geneeskd (2004) 1.39
Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 1.35
A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart (2003) 1.35
Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA (2001) 1.34
Accurate measurement of left ventricular ejection fraction by three-dimensional echocardiography. A comparison with radionuclide angiography. Circulation (1996) 1.32
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32
Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J (2003) 1.32
EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging (2008) 1.29
Radiofrequency catheter ablation of ventricular tachycardia guided by intracardiac echocardiography. Eur J Echocardiogr (2004) 1.25
Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. Am J Cardiol (2000) 1.25
Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients. Atherosclerosis (2009) 1.24
Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol (2001) 1.17
Clinical application of CT coronary angiography: state of the art. Heart Lung Circ (2010) 1.17
Intracardiac pseudotumor caused by mitral annular calcification. Eur J Echocardiogr (2005) 1.17
Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation (1999) 1.17
Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. J Nucl Med (1998) 1.17